+ All Categories
Home > Health & Medicine > Mongolia one day prevalence study

Mongolia one day prevalence study

Date post: 23-May-2015
Category:
Upload: serod-khuyagaa
View: 2,270 times
Download: 0 times
Share this document with a friend
Popular Tags:
32
One day prevalence study 1 Mongolia, January/February 2012 Walter Popp, University Clinics Essen, Germany
Transcript
Page 1: Mongolia   one day prevalence study

One day prevalence study

Mongolia, January/February 2012

Walter Popp, University Clinics Essen, Germany

1

One day prevalence study

Mongolia, January/February 2012

Walter Popp, University Clinics Essen, Germany

Page 2: Mongolia   one day prevalence study

Prevalence study (cross-sectional/transverse)

Infections in all patients hospitalized at a given point in time are identified (pointprevalence) in the entire hospital, or on selected units.

Typically, a team of trained investigators visits every patient of the hospital on asingle day, reviewing medical and nursing charts, interviewing the clinicalstaff to identify infected patients, and collecting risk factor data. The outcomemeasure is a prevalence rate.

Performed ideally on a single day or week.They can show the magnitude of HAI, identify changing patterns of HAIs, define

target areas for intervention.

Incidence study (continuous/longitudinal)

Prospective identification of new infections (incidence surveillance) requiresmonitoring of all patients within a defined population for a specified timeperiod.

Patients are followed throughout their stay, and sometimes after discharge (e.g.post-discharge surveillance for surgical site infections).

This type of surveillance provides attack rates, infection ratio and incidence rates.It is more effective in detecting differences in infection rates, to follow trends,to link infections to risk factors, and for inter-hospital and inter-unitcomparisons.

2

Prevalence study (cross-sectional/transverse)

Infections in all patients hospitalized at a given point in time are identified (pointprevalence) in the entire hospital, or on selected units.

Typically, a team of trained investigators visits every patient of the hospital on asingle day, reviewing medical and nursing charts, interviewing the clinicalstaff to identify infected patients, and collecting risk factor data. The outcomemeasure is a prevalence rate.

Performed ideally on a single day or week.They can show the magnitude of HAI, identify changing patterns of HAIs, define

target areas for intervention.

Incidence study (continuous/longitudinal)

Prospective identification of new infections (incidence surveillance) requiresmonitoring of all patients within a defined population for a specified timeperiod.

Patients are followed throughout their stay, and sometimes after discharge (e.g.post-discharge surveillance for surgical site infections).

This type of surveillance provides attack rates, infection ratio and incidence rates.It is more effective in detecting differences in infection rates, to follow trends,to link infections to risk factors, and for inter-hospital and inter-unitcomparisons.

Page 3: Mongolia   one day prevalence study

3

Page 4: Mongolia   one day prevalence study

Continuous surveillance:Active, passive, or a combination of both.

Active surveillance:Daily visits to patient wards/care units to assess patients at-risk of HAI, e.g.,surgical site infection (SSI) or central line–associated bloodstream infection(CLABSI).It requires trained staff.

Passive surveillance:Reporting by individuals outside the infection control team (laboratory-basedsurveillance, extraction from medical records postdischarge, infection notificationby physicians or nurses) is of low sensitivity.Positive laboratory reports do not always indicate infection, and negative ones donot always mean infection is absent.

Case finding using active and passive surveillance by an IPC practitionerincreases correct detection of HAIs from approximately 25% to >85%.In continuous surveillance, only incidence cases of HAI should be reported.

4

Continuous surveillance:Active, passive, or a combination of both.

Active surveillance:Daily visits to patient wards/care units to assess patients at-risk of HAI, e.g.,surgical site infection (SSI) or central line–associated bloodstream infection(CLABSI).It requires trained staff.

Passive surveillance:Reporting by individuals outside the infection control team (laboratory-basedsurveillance, extraction from medical records postdischarge, infection notificationby physicians or nurses) is of low sensitivity.Positive laboratory reports do not always indicate infection, and negative ones donot always mean infection is absent.

Case finding using active and passive surveillance by an IPC practitionerincreases correct detection of HAIs from approximately 25% to >85%.In continuous surveillance, only incidence cases of HAI should be reported.

Page 5: Mongolia   one day prevalence study

Post-discharge surveillance

A common question of surveillance programmesis:Do you need to include post-dischargesurveillance in the surveillance plan?

5

Page 6: Mongolia   one day prevalence study

Figure 4.2 depicts a short prevalence survey of seven days.Six patients were surveyed, and two had an active infection:Patient-3 developed a new infection during the surveillance period andPatient-6 had an existing infection.Therefore, the number of infections (numerator) would be two for six(denominator) patients.Patient-5 acquired an infection which is not included because it appearedafter the last day of the survey.

6

Page 7: Mongolia   one day prevalence study

7

Page 8: Mongolia   one day prevalence study

Definitions for HAI

Definitions should distinguish between HAI and community-acquired infection (CAI).HAIs can be defined generally as “An infection occurring in apatient during the process of care in a hospital or other health-care facility which was not present or incubating at the time ofadmission. This includes infections acquired in the health-carefacility but appearing after discharge and also occupationalinfections among health-care workers of the facility”.

Cutt-off point 48 hours after admission is typically used todistinguish between HAI and CAI.

Well-established criteria for HAIs have been developed by theU.S. Centers for Disease Control and Prevention (CDC).

8

Definitions for HAI

Definitions should distinguish between HAI and community-acquired infection (CAI).HAIs can be defined generally as “An infection occurring in apatient during the process of care in a hospital or other health-care facility which was not present or incubating at the time ofadmission. This includes infections acquired in the health-carefacility but appearing after discharge and also occupationalinfections among health-care workers of the facility”.

Cutt-off point 48 hours after admission is typically used todistinguish between HAI and CAI.

Well-established criteria for HAIs have been developed by theU.S. Centers for Disease Control and Prevention (CDC).

Page 9: Mongolia   one day prevalence study

9

Page 10: Mongolia   one day prevalence study

10

Page 11: Mongolia   one day prevalence study

11

Page 12: Mongolia   one day prevalence study

Problems

Influence of the persons doing surveillance (standing/reputationin the hospital staff?)

Problem of small numbers in short periods (e.g. 3 months)

Problems of diagnosis:Sepsis: the more cases the more blood culturesPneumonia: who makes the x-ray diagnosis?Politics of antibiotics: more antibiotics less infections?Microbiologic confirmation of infections?

Numbers of indicator operations big enough?e.g. infection rate about 2 % in Germany

12

Problems

Influence of the persons doing surveillance (standing/reputationin the hospital staff?)

Problem of small numbers in short periods (e.g. 3 months)

Problems of diagnosis:Sepsis: the more cases the more blood culturesPneumonia: who makes the x-ray diagnosis?Politics of antibiotics: more antibiotics less infections?Microbiologic confirmation of infections?

Numbers of indicator operations big enough?e.g. infection rate about 2 % in Germany

Page 13: Mongolia   one day prevalence study

13

Page 14: Mongolia   one day prevalence study

14

Page 15: Mongolia   one day prevalence study

15

Page 16: Mongolia   one day prevalence study

16

Page 17: Mongolia   one day prevalence study

17

Page 18: Mongolia   one day prevalence study

18

Page 19: Mongolia   one day prevalence study

19

Page 20: Mongolia   one day prevalence study

20

Page 21: Mongolia   one day prevalence study

21

Page 22: Mongolia   one day prevalence study

22

Page 23: Mongolia   one day prevalence study

23

Page 24: Mongolia   one day prevalence study

24

Page 25: Mongolia   one day prevalence study

25

Page 26: Mongolia   one day prevalence study

26

Page 27: Mongolia   one day prevalence study

27

Page 28: Mongolia   one day prevalence study

28

Page 29: Mongolia   one day prevalence study

29

Page 30: Mongolia   one day prevalence study

30

Page 31: Mongolia   one day prevalence study

31

Page 32: Mongolia   one day prevalence study

Thank you for your attention!

32


Recommended